Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/79924
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Bisphosphonate-associated osteonecrosis of the external auditory canal
Author: Wickham, N.
Crawford, A.
Carney, A.
Goss, A.
Citation: Journal of Laryngology and Otology, 2013; 127(S2):51-53
Publisher: Headley Brothers Ltd
Issue Date: 2013
ISSN: 0022-2151
1748-5460
Statement of
Responsibility: 
N Wickham, A Crawford, A S Carney, A N Goss
Abstract: <h4>Background</h4>Osteonecrosis is a benign condition characterised by necrotic exposed bone, and is associated with bisphosphonate use. Osteonecrosis of the external auditory canal is rare, with only a few reported cases.<h4>Method</h4>Two case reports of temporal bone osteonecrosis are presented.<h4>Results</h4>A 64-year-old man with a history of immunoglobulin G kappa multiple myeloma developed a right external auditory canal ulcer 6 years after commencement on clodronate. A 72-year-old woman taking alendronate for osteoporosis, initially diagnosed and treated for right-sided otitis externa, was found to have underlying exposed bone in the right external auditory canal, with a computed tomography scan confirming destruction of the temporal bone.<h4>Conclusion</h4>With increasing use of both oral and intravenous bisphosphonates in the community for benign conditions such as osteoporosis and for malignant conditions such as breast cancer and multiple myeloma, the diagnosis of bisphosphonate-associated osteonecrosis should always be considered in patients with a temporal bone lesion, and a relevant drug history taken.
Keywords: Bone Diseases
Bisphosphonates
Osteonecrosis
Jaw
Ear Canal
Temporal Bone
Rights: Copyright © JLO (1984) Limited 2013
DOI: 10.1017/S002221511300100X
Published version: http://dx.doi.org/10.1017/s002221511300100x
Appears in Collections:Aurora harvest 4
Dentistry publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.